Trial Profile
A Worldwide, Open Label, Clinical Trial to Examine the Long Term Safety and Tolerability of Rizatriptan in Pediatric Migraineurs for the Treatment of Migraine With or Without Aura.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 May 2022
Price :
$35
*
At a glance
- Drugs Rizatriptan (Primary)
- Indications Migraine with aura; Migraine without aura
- Focus Adverse reactions; Registrational
- Sponsors Organon
- 19 Jul 2019 This trial has been Discontinued in France, according to European Clinical Trials Database.
- 29 Jun 2012 Additional locations identified as reported by as reported by European Clinical Trials Database.
- 03 May 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.